NTCP-based prediction of maculopathy after proton therapy or Ruthenium-106 brachytherapy for choroidal melanomas

Espensen, CA, Thariat, J, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (6 more authors) (2017) NTCP-based prediction of maculopathy after proton therapy or Ruthenium-106 brachytherapy for choroidal melanomas. In: Investigative Opthalmology & Visual Science. 2017 ARVO Annual Meeting, 07-11 May 2017, Baltimore, Md, USA. Association for Research in Vision and Opthalmology .

Metadata

Authors/Creators:
Dates:
  • Accepted: 3 March 2017
  • Published: June 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 12 Jun 2018 14:47
Last Modified: 13 Jun 2018 10:16
Published Version: http://iovs.arvojournals.org/article.aspx?articlei...
Status: Published
Publisher: Association for Research in Vision and Opthalmology
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)